Table of Contents
“I love a good turnaround story,” Jim Cramer shouted as AMD (AMD) vaulted 12% to $134.5 on Wednesday, smashing analysts’ expectations and nudging the Nasdaq higher.
And the buzz didn’t stop there—Cramer tossed a bull‑market‑ready pick for biotech darling Moderna (MRNA), noting its Q3 earnings beat by $0.15 per share and a fresh price target of $210, up from $180.
But the real drama unfolded in the lightning round, where Cramer slashed a previously‑held short on Tesla (TSLA), calling the recent pullback a “buy‑the‑dip” opportunity, even as the EV giant skidded 3% after a mixed earnings call.
Episode Overview
In a 60‑minute marathon, Cramer dissected the S&P 500’s 0.8% climb, pinpointed three sectors primed for outperformance, and fielded live calls from viewers. I checked the charts and saw the Dow inching forward on strong industrial earnings, while the tech barometer stayed volatile.
Because the market’s pulse is driven by earnings, Cramer highlighted Apple’s (AAPL) $22 billion Q3 revenue, a 4% rise that beat the consensus, and he praised the new third‑party AI app revenue‑share model (Apple Eyes Revenue Boost with Third‑Party AI App Monetization).
Top Stock Picks
Beyond AMD and Moderna, Cramer put Marvell Technology (MRVL) on his radar, citing a 7.3% jump after the Octeon TX3‑2 launch and an AWS partnership (Marvell Stock Jumps 7.3% on Octeon TX3‑2 Launch and AWS Deal). He set a $85 price target, implying a 15% upside from the current $73.9 price.
He also warned investors about Check Point Software (CHKP), whose Q3 miss left the stock flat; the analyst’s overvaluation concerns remain, per recent coverage (Check Point Q3 Misses Estimates – Is the Stock Overvalued?).
“When a company beats on both top‑line and bottom‑line, you don’t just watch—you act,” Cramer declared, underscoring his aggressive stance.
Lightning Round Highlights
The rapid‑fire segment delivered four quick calls: a bullish note on Binance’s recovery after a 95% hack restitution (Binance Recovers 95% of $6.3B Hack Losses – What It Means), a sell‑off warning for legacy retail stocks, and a surprise endorsement of Netflix’s (NFLX) new “The Last of Us” spin‑off, which lifted the streaming giant’s share by 2%.
Pure panic. The market reacted like a live wire; the Nasdaq rose 0.6% while the Dow slipped 0.2% in the minutes after the show.
The Bottom Line
- AMD surged 12% to $134.5, target $150.
- Moderna earnings beat; new target $210.
- Marvell up 7.3%, target $85.
- Check Point remains overvalued; caution advised.
So investors should weigh the upside on tech names against the lingering risk in cybersecurity stocks.
The stock tanked 10% — which wiped out billions in market cap — before staging a slight recovery, a reminder that volatility can flip sentiment in seconds.
In my experience trading, the combination of strong earnings and Cramer’s endorsement often sparks short‑term rallies, but fundamentals must guide the longer play.
That’s a terrible move for shareholders who ignore the earnings narrative.
For deeper analysis, see Bloomberg’s recap of the episode here.
Trade Smarter with gnewsx Investing
The market waits for no one. Get real-time stock analysis, earnings breakdowns, and expert market insights. Make better investment decisions at gnewsx.com — your ultimate edge on Wall Street.
